No Data
Earnings Preview: BTAI to Report Financial Results Pre-market on November 14
$BioXcel Therapeutics(BTAI.US)$ is scheduled to release its financial results pre-market on November 14 ET. Earnings PreviewAnalysts estimate $BioXcel Therapeutics(BTAI.US)$ to post revenue of USD1.33
BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024
BioXcel Therapeutics to Present at ThinkEquity Conference
H.C. Wainwright Maintains BioXcel Therapeutics(BTAI.US) With Buy Rating, Cuts Target Price to $5
BioXcel Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Express News | BioXcel Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $5 From $7
No Data
No Data